Analyzing MM patient cohort GSE2658 indicated SAE2 level was negatively associated with PU.1 (gene name SPI1) expression (Supplementary Fig. S5C), suggesting SUMOylation inhibition might increase PU.1 to decrease IRF4 expression. Here, UBA2 is linked to Miyoshi myopathy.